List of works - Abdo A. Elfiky

2′-Methylguanosine Prodrug (IDX-184), Phosphoramidate Prodrug (Sofosbuvir), Diisobutyryl Prodrug (R7128) Are Better Than Their Parent Nucleotides and Ribavirin in Hepatitis C Virus Inhibition: A Molecular Modeling Study

article published in 2015

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

scientific article published on 28 February 2020

COVID-19 spike-host cell receptor GRP78 binding site prediction

scientific article published on 10 March 2020

Clean Grinding Technique: A Facile Synthesis and In Silico Antiviral Activity of Hydrazones, Pyrazoles, and Pyrazines Bearing Thiazole Moiety against SARS-CoV-2 Main Protease (Mpro)

scientific article published on 06 October 2020

Correlation to protein conformation of Wide-angle X-ray Scatter parameters

scientific article

Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an <i>in silico</i> perspective

publication published on 05 May 2022

Ebola virus glycoprotein GP1-host cell-surface HSPA5 binding site prediction

scientific article published on 14 April 2020

GRP78: A cell's response to stress

scientific article published on 09 April 2019

GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective

scientific article published on 23 October 2021

Human papillomavirus E6: Host cell receptor, GRP78, binding site prediction

scientific article published on 28 February 2020

IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study

scientific article published on 04 March 2016

In silico estrogen-like activity and in vivo osteoclastogenesis inhibitory effect of Cicer arietinum extract

Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures.

scientific article published in May 2018

Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV

scientific article published on 16 October 2019

Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds.

scientific article published on 18 September 2017

Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase

scientific article published on 20 January 2022

Molecular modeling comparison of the performance of NS5b polymerase inhibitor (PSI-7977) on prevalent HCV genotypes

scientific article published on January 2013

Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitors to unveil a hope against COVID-19

scientific article published on 26 March 2022

Natural products may interfere with SARS-CoV-2 attachment to the host cell

scientific article published on 27 April 2020

Novel Guanosine Derivatives against MERS CoV polymerase: An in silico perspective

scientific article published on 20 April 2020

Novel Guanosine Derivatives as Anti-HCV NS5b polymerase: A QSAR and Molecular Docking Study

scientific article published on 01 January 2019

Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective

scientific article published on 24 June 2021

Novel guanosine derivatives against Zika virus polymerase in silico

scientific article published on 29 August 2019

Novel inhibitors against wild-type and mutated HCV NS3 serine protease: an in silico study

scientific article published on 21 March 2019

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective

scientific article published on 12 September 2021

Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses

scientific article

Recognition of gluconeogenic enzymes; Icl1, Fbp1, and Mdh2 by Gid4 ligase: A molecular docking study

scientific article published on 20 December 2019

Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective

scientific article published on 27 December 2019

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective

publication published on 21 May 2021

Reply to a letter to the editor

scientific article published on 22 April 2020

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study

scientific article published on 25 March 2020

SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective

scientific article published on 26 April 2020

The Electronic and Quantitative Structure Activity Relationship Properties of Modified Telaprevir Compounds as HCV NS3 Protease Inhibitors

The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico

scientific article published on 03 January 2021

Theoretical Study on Modified Boceprevir Compounds as NS3 Protease Inhibitors